Cancer Immunology
| Weitere Verfasser: |
Subramanian, Subree
, [HerausgeberIn]
Zhao, Xianda , [HerausgeberIn] |
|---|---|
| Umfang/Format: |
1 online resource (316 pages). |
| Schlagworte: | |
| Online Zugang: |
DOAB: download the publication DOAB: description of the publication |
| LEADER | 04159namaa2201405ui 4500 | ||
|---|---|---|---|
| 001 | 003028158 | ||
| 005 | 20221228154431.0 | ||
| 003 | DE-2553 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220111s2021 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-2572-3 | ||
| 020 | |a 9783036525730 | ||
| 020 | |a 9783036525723 | ||
| 040 | |a oapen |c oapen |b eng |d DE-2553 |e rda | ||
| 024 | 7 | |a 10.3390/books978-3-0365-2572-3 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Subramanian, Subree |e editor | |
| 264 | |b MDPI - Multidisciplinary Digital Publishing Institute, |c 2021. | ||
| 700 | 1 | |a Zhao, Xianda |e editor | |
| 700 | 1 | |a Subramanian, Subree |e other | |
| 700 | 1 | |a Zhao, Xianda |e other | |
| 245 | 1 | 0 | |a Cancer Immunology |
| 300 | |a 1 online resource (316 pages). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a NKG2D | ||
| 653 | |a CAR T | ||
| 653 | |a IL-7 | ||
| 653 | |a prostate cancer | ||
| 653 | |a cell therapy | ||
| 653 | |a CD19-CAR-T | ||
| 653 | |a B cell aplasia | ||
| 653 | |a KIR | ||
| 653 | |a PD-1 | ||
| 653 | |a inhibitory CAR | ||
| 653 | |a tumor-infiltrating lymphocytes | ||
| 653 | |a tumor microenvironment | ||
| 653 | |a immunotherapy | ||
| 653 | |a NK cells | ||
| 653 | |a cancer stem cells (CSCs) | ||
| 653 | |a antibody-dependent cellular cytotoxicity (ADCC) | ||
| 653 | |a differentiation | ||
| 653 | |a cytotoxicity | ||
| 653 | |a IFN-γ | ||
| 653 | |a osteoclasts | ||
| 653 | |a MICA/B mAb | ||
| 653 | |a DNA methylation | ||
| 653 | |a RNA methylation | ||
| 653 | |a S-adenosylmethionine (SAM) | ||
| 653 | |a cancer | ||
| 653 | |a innate immunity | ||
| 653 | |a adaptive immunity | ||
| 653 | |a T cells | ||
| 653 | |a m6A | ||
| 653 | |a PD-L1 | ||
| 653 | |a resistance | ||
| 653 | |a immune checkpoints | ||
| 653 | |a cancer vaccine | ||
| 653 | |a combination immunotherapy | ||
| 653 | |a TCR diversity | ||
| 653 | |a organ transplantation | ||
| 653 | |a carcinoma | ||
| 653 | |a epidemiologic studies | ||
| 653 | |a immunosuppression | ||
| 653 | |a CTLA-4 | ||
| 653 | |a Treg cells | ||
| 653 | |a immune checkpoint inhibitors | ||
| 653 | |a CD28 | ||
| 653 | |a antigen-presenting cells | ||
| 653 | |a IL15 | ||
| 653 | |a colon cancer | ||
| 653 | |a melanoma | ||
| 653 | |a uveal | ||
| 653 | |a BAP1 | ||
| 653 | |a anti-PD-1 | ||
| 653 | |a anti-CTLA-4 | ||
| 653 | |a TIL | ||
| 653 | |a classical and endemic Kaposi Sarcoma | ||
| 653 | |a systemic treatment | ||
| 653 | |a multi-state modelling | ||
| 653 | |a treatment free interval | ||
| 653 | |a chemotherapy | ||
| 653 | |a interferon | ||
| 653 | |a triple negative breast cancer | ||
| 653 | |a immunomodulation | ||
| 653 | |a bispecific antibody | ||
| 653 | |a sortase A | ||
| 653 | |a chemo-enzymatic approach | ||
| 653 | |a anti-CD20 antibody | ||
| 653 | |a Fab | ||
| 653 | |a BiFab | ||
| 653 | |a colorectal cancer | ||
| 653 | |a dendritic cells | ||
| 653 | |a Atypical Chemokine Receptor 4 (ACKR4) | ||
| 653 | |a T-cell priming | ||
| 653 | |a immune checkpoint blockade | ||
| 653 | |a primary liver cancer | ||
| 653 | |a kynurenine pathway | ||
| 653 | |a immune evasion | ||
| 653 | |a indoleamine 2,3 dioxygenase 1 | ||
| 653 | |a tryptophan 2,3 dioxygenase 2 | ||
| 653 | |a IDO inhibitor | ||
| 653 | |a antigen presenting cells | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4727 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/77108 |7 0 |z DOAB: description of the publication |
| 590 | |a Online publication | ||
| 590 | |a ebookoa1222 | ||
| 590 | |a doab | ||
| 942 | |2 z |c EB | ||
| 999 | |c 3028158 |d 1431913 | ||
| 952 | |0 0 |1 0 |2 z |4 0 |6 ONLINE |7 1 |9 973797 |R 2022-12-28 14:44:31 |a DAIG |b DAIG |l 0 |o Online |r 2022-12-28 |y EB | ||
